These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Influence of genotype and the organ of origin on the subtype of T-cell in Moloney lymphomas induced by transfer of preleukemic cells from athymic and thymus-bearing mice. Asjö B, Skoog L, Palminger I, Wiener F, Isaak D, Cerny J, Fenyö EM. Cancer Res; 1985 Mar 20; 45(3):1040-5. PubMed ID: 3871660 [Abstract] [Full Text] [Related]
31. Cellular tropism and localization in the rodent nervous system of a neuropathogenic variant of Friend murine leukemia virus. Hoffman PM, Cimino EF, Robbins DS, Broadwell RD, Powers JM, Ruscetti SK. Lab Invest; 1992 Sep 20; 67(3):314-21. PubMed ID: 1405490 [Abstract] [Full Text] [Related]
32. Infection of developing mouse embryos with murine leukemia virus: tissue specificity and genetic transmission of the virus. Jaenisch R, Dausman J, Cox V, Fan H. Hamatol Bluttransfus; 1976 Sep 20; 19():341-56. PubMed ID: 1010468 [Abstract] [Full Text] [Related]
33. A Moloney murine leukemia virus-based retrovirus with 4070A long terminal repeat sequences induces a high incidence of myeloid as well as lymphoid neoplasms. Wolff L, Koller R, Hu X, Anver MR. J Virol; 2003 Apr 20; 77(8):4965-71. PubMed ID: 12663802 [Abstract] [Full Text] [Related]
34. Immunological mechanisms in the pathogenesis of virus-induced murine leukemia. I. Autoreactivity. Proffitt MR, Hirsch MS, Gheridian B, McKenzie IF, Black PH. Int J Cancer; 1975 Feb 15; 15(2):221-9. PubMed ID: 1079204 [Abstract] [Full Text] [Related]
35. Immunosuppression in mice after inoculation with 334C, a murine lymphatic leukemia-inducing virus. Schenk PJ, Buffett RF. J Natl Cancer Inst; 1977 Mar 15; 58(3):665-71. PubMed ID: 190412 [Abstract] [Full Text] [Related]
36. Natural history of M-MSV tumors in mice carrying endogenized Moloney leukemia virus. Chieco-Bianchi L, D'Andrea E, De Rossi A, Zanovello P, Ronchese F, Collavo D. Haematol Blood Transfus; 1983 Mar 15; 28():275-9. PubMed ID: 6602736 [No Abstract] [Full Text] [Related]
37. T and B lymphocyte susceptibility to murine leukemia virus moloney. Isaak DD, Cerny J. Infect Immun; 1983 Jun 15; 40(3):977-84. PubMed ID: 6602095 [Abstract] [Full Text] [Related]
38. Immunosuppression by Moloney leukemia virus: lack of correlation between virus replication and the immunosuppressive effect. Cerny J, Proffitt MR, Essex M. J Natl Cancer Inst; 1976 Apr 15; 56(4):819-22. PubMed ID: 768506 [Abstract] [Full Text] [Related]
39. Moloney virus (M-MuLV) leukemogenesis: virus spread, antibody production and antigenic expression in neonatally virus-inoculated young mice. Asjö B, Fenyö EM, Klein G. Int J Cancer; 1981 Jul 15; 28(1):65-70. PubMed ID: 7309282 [Abstract] [Full Text] [Related]
40. Induction of histiocytomas by pristane treatment of mice chronically infected with Moloney murine leukemia virus. Nobis P, Löhler J. Haematol Blood Transfus; 1983 Jul 15; 28():280-1. PubMed ID: 6862304 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]